IRIS
MURDACA, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 17.236
AS - Asia 777
SA - Sud America 144
NA - Nord America 69
AF - Africa 8
Totale 18.234
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 17.221
SG - Singapore 299
CN - Cina 239
VN - Vietnam 173
BR - Brasile 88
US - Stati Uniti d'America 40
AR - Argentina 34
MX - Messico 23
HK - Hong Kong 22
ID - Indonesia 14
BD - Bangladesh 8
IQ - Iraq 8
RU - Federazione Russa 7
PY - Paraguay 5
CO - Colombia 4
EC - Ecuador 4
DO - Repubblica Dominicana 3
IN - India 3
VE - Venezuela 3
ZA - Sudafrica 3
AZ - Azerbaigian 2
BO - Bolivia 2
CL - Cile 2
GB - Regno Unito 2
MA - Marocco 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
CA - Canada 1
CR - Costa Rica 1
EG - Egitto 1
ES - Italia 1
ET - Etiopia 1
FI - Finlandia 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
MY - Malesia 1
PE - Perù 1
PH - Filippine 1
RS - Serbia 1
TR - Turchia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 18.234
Salva come PNG Salva come JPEG
Città #
Genova 9.464
Genoa 5.055
Rapallo 1.398
Vado Ligure 1.249
Singapore 119
Beijing 80
Ho Chi Minh City 54
Bordighera 47
Hanoi 39
Ashburn 28
Hong Kong 22
Mexico City 18
Haiphong 15
Tianjin 14
Biên Hòa 7
Bắc Ninh 5
Quảng Ngãi 5
Rio de Janeiro 5
São Paulo 5
Da Nang 4
Asunción 3
Baghdad 3
Quito 3
Salvador 3
Santo Domingo 3
Thái Nguyên 3
Baku 2
Barletta 2
Belo Horizonte 2
Brasília 2
Bình Dương 2
Campos dos Goytacazes 2
Cape Town 2
Ciserano 2
Council Bluffs 2
Dhaka 2
Jakarta 2
Jinan 2
La Paz 2
La Plata 2
Maceió 2
Monte Grande 2
New York 2
Phủ Lý 2
Poplar 2
Quảng Nam Province 2
Resistencia 2
Santa Bárbara d'Oeste 2
Thái Bình 2
Acapulco de Juárez 1
Addis Ababa 1
Agadir 1
Altamira 1
Amman 1
Ananindeua 1
Apóstoles 1
Araçatuba 1
Arrecifes 1
Athens 1
Aurangabad 1
Boa Vista 1
Boardman 1
Bonito 1
Boston 1
Buenos Aires 1
Buon Ma Thuot 1
Burzaco 1
Cabo Frio 1
Cachoeira do Sul 1
Cachoeirinha 1
Cairo 1
Camaquã 1
Campo Largo 1
Can Tho 1
Canoas 1
Capelinha 1
Caracas 1
Carmo de Minas 1
Cascavel 1
Caxias do Sul 1
Changchun 1
Chennai 1
Chicago 1
Clorinda 1
Concordia 1
Cordeirópolis 1
Cruz Alta 1
Cruzeiro 1
Curitiba 1
Córdoba 1
Don Torcuato 1
Dubai 1
Duhok 1
Duque de Caxias 1
Ecatepec 1
El Calafate 1
Engativá 1
Ensenada 1
Erbil 1
Erechim 1
Totale 17.748
Salva come PNG Salva come JPEG
Nome #
Non-antigen-specific CD8(+) T suppressor lymphocytes in diseases characterized by chronic immune responses and inflammation. 251
Infection risk associated with anti-TNF-α agents: A review 216
A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer 205
Beneficial effects of long-term treatment with bosentan on the development of pulmonary arterial hypertension in patients with systemic sclerosis 195
Autoimmune central diabetes insipidus in a patient with ureaplasma urealyticum infection and review on new triggers of immune response. 194
Autoimmune intrahepatic cholangiopathy associated with antiphospholipid antibody syndrome 187
Vaccine-preventable infections in Systemic Lupus Erythematosus 182
Characteristics of current heart failure patients admitted to internal medicine vs. cardiology hospital units: the VASCO study 179
Adalimumab for the treatment of immune-mediated diseases: an update on old and recent indications 177
TNF-α gene polymorphisms: association with disease susceptibility and response to anti-TNF-α treatment in psoriatic arthritis 176
Immunogenicity of infliximab and adalimumab: What is its role in hypersensitivity and modulation of therapeutic efficacy and safety? 176
Allergen-driven HLA-G expression and secretion in peripheral blood mononuclear cells from allergic rhinitis patients 174
The antiphospholipid syndrome: from pathophysiology to treatment 171
Adult iatrogenic Cushing's syndrome induced by topical skin corticosteroid misuse 166
Soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis 164
Behavior of soluble HLA-A, -B, -C and HLA-G molecules in patients with chronic hepatitis C virus infection undergoing pegylated interferon-α and ribavirin treatment: potential role as markers of response to antiviral therapy 164
Treatment Algorithms for Systemic Sclerosis According to Experts 162
General surgery, translational lymphology and lymphatic surgery 161
Emerging biological drugs: a new therapeutic approach for Systemic Lupus Erythematosus. An update upon efficacy and adverse events 158
Update upon efficacy and safety of etanercept for the treatment of spondyloarthritis and juvenile idiopathic arthritis 158
Iloprost use and medical management of systemic sclerosis-related vasculopathy in Italian tertiary referral centers: results from the PROSIT study 157
Behavior of serum human major histocompatibility complex class I antigen levels in human immunodeficiency virus-infected patients during antiretroviral therapy: correlation with clinical outcome 156
Immunoregulatory Role of HLA-G in Allergic Diseases 154
Soluble HLA-G molecule in patients with perennial allergic rhinitis. 154
Impact of pharmacogenomics upon the therapeutic response to etanercept in psoriasis and psoriatic arthritis 152
Body mass index in Th1 and Th2 diseases. 151
Vdelta1 T lymphocytes producing IFN-gamma and IL-17 are expanded in HIV-1-infected patients and respond to Candida albicans 149
ACUTE CARDIAC FAILURE AND IGA NEPHROPATHY: AN UNCOMMON SLE ONSET 149
Soluble serum HLA-G and HLA-A, -B, -C molecules in patients with seasonal allergic rhinitis exposed to pollens. 148
Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and interleukin-6 serum changes after 12 months of therapy. 146
A rare hepatic mass in an Italian resident 146
Anti-tumour necrosis factor-a treatment with infliximab for disseminated granuloma annulare 144
Pharmacogenetics of etanercept: role of TNF-α gene polymorphisms in improving its efficacy 144
Adipokines and sublingual immunotherapy: preliminary report. 143
Serum vascular endothelial growth factor and sublingual immunotherapy 143
Current recommendation to reduce the burden of bacterial and viral infections in patients affected by systemic lupus erythematosus 143
Phase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adults. 138
Plicometer skin test: a new technique for the evaluation of cutaneous involvement in systemic sclerosis. 137
An Uncommon Presentation of Pancreatic Carcinoma 136
Genetic factors and systemic sclerosis 136
Apoptosis in the Homeostasis of the Immune System and in Human Immune Mediated Diseases 135
Update upon the infection risk in patients receiving TNF alpha inhibitors 135
Use of leflunomide plus TNF-α inhibitors in rheumatoid arthritis 134
Hypoadiponectinemia in lipodystrophic HIV individuals: a metabolic marker of subclinical cardiac damage 134
A case of transposition of the great arteries in a female infant of a HIV-1 infected woman. Potential teratogenic effect of antiretroviral drugs. 134
Interleukin-2 therapy in patients with HIV infection 133
Traditional and non traditional risk factors in accelerated atherosclerosis in systemic lupus erythematosus: role of vascular endothelial growth factor (VEGATS Study). 133
Serum adiponectin levels in patients with pollen-induced allergic rhinitis 131
Serum interleukin-17 levels are related to clinical severity in allergic rhinitis 131
Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A, -B, -C antigens and potential role in immune-reconstitution. 131
Endothelial dysfunction in rheumatic autoimmune diseases. 131
Monkeypox 2024 outbreak: Fifty essential questions and answers 131
Free radicals and endothelial dysfunction: potential positive effects of TNF-α inhibitors. 130
Potential use of TNF-α inhibitors in systemic sclerosis. 130
Two year sublingual immunotherapy affects serum leptin 129
Low expression of inhibitory natural killer receptors in CD8 cytotoxic T lymphocytes in long-term non-progressor HIV-1-infected patients 129
Intima-media thickness: a marker of accelerated atherosclerosis in women with systemic lupus erythematosus 129
Effects of antagomiRs on different lung diseases in human, cellular, and animal models 128
Sublingual immunotherapy reduces soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis. 127
Postexposure HIV prophylaxis regimen. 127
Lymphatic microsurgery to treat lymphedema: techniques and indications for better results. 126
Current views on diagnostic approach and treatment of lymphedema 126
Drug-induced aminotransferase alterations during antiretroviral HIV post-exposure prophylaxis 125
Effects of TNF-α inhibitors upon the mechanisms of action of VEGF. 125
HLA-G expression in gastric carcinoma: clinicopathological correlations and prognostic impact 125
Remission of Brucella endocarditis in a patient with mitral valve mechanical prosthesis by antibiotic therapy alone: a case report 123
Determination of lymphotoxin-α levels in patients with psoriatic arthritis undergoing etanercept treatment 123
Pharmacogenetics and future therapeutic scenarios: what affects the prediction of response to treatment with etanercept? 122
Anti-TNF-alpha inhibitors: a new therapeutic approach for inflammatory immune-mediated diseases: an update upon efficacy and adverse events. 121
Hepatic safety and postexposure prophylaxis 121
Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection: A case control study 121
Significant NK cell activation associated with decreased cytolytic function in peripheral blood of HIV-1 infected patients 120
The role of Th17 lymphocytes in the autoimmune and chronic inflammatory diseases 120
Influenza and pneumococcal vaccinations of patients with systemic lupus erythematosus: Current views upon safety and immunogenicity. 120
Serum IL-17 after one course of sublingual immunotherapy in allergic rhinitis to birch 120
Selective TNF-α inhibitor-induced injection site reactions. 119
Detection of influenza A(H1N1)pdm09 virus in a patient travelling from Shanghai to Italy in July 2018: An uncommon clinical presentation in a non-seasonal period 119
Immunogenicity of infliximab and adalimumab 117
Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART 116
Esophageal baseline impedance levels allow the identification of esophageal involvement in patients with systemic sclerosis 115
Efficacy and safety of etanercept in chronic immune-mediated disease. 115
Accelerated atherosclerosis in patients with Systemic Lupus Erythematosus. 114
HLA-G Expressing Immune Cells in Immune Mediated Diseases 114
Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study 114
Soluble HLA-G serum levels in patients with the Acquired Immunodeficiency Syndrome affected by different AIDS-defining conditions before and after anti-retroviral treatment 113
Influenza and pneumococcal vaccinations of patients with systemic lupus erythematosus: current evidences upon safety and immunogenicity 113
Recurrent intestinal perforation associated with thrombosis of inferior vena cava: uncommon presentation of antiphospholipid syndrome. 112
Update upon efficacy and safety of TNF-α inhibitors. 112
Emerging role of vitamin D in autoimmune diseases: An update on evidence and therapeutic implications 112
A compilation answering 50 questions on Monkeypox virus and the current Monkeypox outbreak 112
Emerging biologic drugs for the treatment of rheumatoid arthritis 111
Regulation of gammadelta T cell survival by soluble HLA-I: Involvement of CD8 and activating killer Ig-like receptors. 110
Antiphospholipid syndrome and reversible posterior leukoencephalopathy syndrome. 110
Current therapies for the treatment of systemic sclerosis-related pulmonary arterial hypertension: efficacy and safety. 110
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence 109
Differential diagnosis in recurrent intestinal perforation: chronic inflammatory disease with intestinal lymphedema or antiphospholipid syndrome? 109
Differential disappearance of inhibitory natural killer cell receptors during HAART and possible impairment of HIV-1-specific CD8 cytotoxic T lymphocytes. 108
Expression of membrane-bound human leucocyte antigen-G in systemic sclerosis and systemic lupus erythematosus 108
Nocturia: an uncommon presentation of lower-limb lymphedema. 107
ENDOTHELIAL DYSFUNCTION IN PSORIATIC ARTHRITIS: EVALUATION BY ENDOTHELIAL-DEPENDENT FLOW-MEDIATED DILATION AND CORONARY FLOW RESERVE 103
Totale 13.804
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.668
article - articoli 66.668
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 133.336
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021854 0 0 0 0 0 183 155 115 105 108 95 93
2021/20221.701 43 116 123 190 56 126 78 406 101 154 70 238
2022/20231.671 143 105 28 163 298 285 10 145 261 15 185 33
2023/20241.007 39 149 19 133 66 149 95 80 54 15 63 145
2024/20253.280 111 219 110 236 418 309 363 522 120 152 329 391
2025/20262.978 689 261 565 650 744 69 0 0 0 0 0 0
Totale 18.688